We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

To accompany today’s extract from *Alien Territory: An Experimental, Radical & Irrelevant Playlist from 1970s San Diego*, author Bill Perrine has curated a special playlist of off-beat and ...

Newly released data reveals that seven out of 67 children treated with Bluebird Bio Inc's BLUE gene therapy for a severe neurological disorder in clinical trials have developed blood cancers.